Effects of prescription stimulants on drug overdoses
Impact of prescription stimulants on the drug overdose epidemic
This study is looking at how the rise in prescription stimulants, like amphetamines, might be linked to more drug overdoses during the COVID-19 pandemic, and it aims to find out if these medications can help people struggling with substance use issues stay sober and reduce overdose risks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mclean Hospital NIH-funded |
| Lab location | 1 site (Belmont, United States) |
| Project ID | NIH-11059981 on NIH RePORTER |
What this research studies
This research investigates the relationship between the increasing use of prescription stimulants, particularly amphetamines, and the rise in drug overdoses, especially during the COVID-19 pandemic. By analyzing real-world data, the study aims to understand whether the use of these stimulants contributes to the transition from prescription to illicit drug use, leading to fatal overdoses. The research will also explore if prescription stimulants can help individuals with substance use disorders achieve short-term abstinence and whether this has any impact on overdose rates.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 who have a history of stimulant use or substance use disorders.
Not a fit: Patients who do not use prescription stimulants or have no history of substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights that help reduce the incidence of drug overdoses linked to stimulant use.
How similar studies have performed: While there is existing research on opioid use and its consequences, this specific investigation into prescription stimulants and their impact on overdoses is relatively novel.
Where this research is happening
Belmont, United States
- Mclean Hospital — Belmont, United States (Active)
Researchers
- Principal investigator: De Nadai, Alessandro Stevens — Mclean Hospital
- Study coordinator: De Nadai, Alessandro Stevens
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.